KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

UiPath (PATH) Research & Development (2020 - 2025)

Historic Research & Development for UiPath (PATH) over the last 6 years, with Q4 2025 value amounting to $96.9 million.

  • UiPath's Research & Development fell 11.03% to $96.9 million in Q4 2025 from the same period last year, while for Oct 2025 it was $389.7 million, marking a year-over-year increase of 629.15%. This contributed to the annual value of $380.7 million for FY2025, which is 1462.84% up from last year.
  • Latest data reveals that UiPath reported Research & Development of $96.9 million as of Q4 2025, which was down 11.03% from $98.3 million recorded in Q3 2025.
  • UiPath's 5-year Research & Development high stood at $99.7 million for Q1 2025, and its period low was $29.2 million during Q1 2021.
  • In the last 5 years, UiPath's Research & Development had a median value of $85.1 million in 2023 and averaged $79.7 million.
  • Its Research & Development has fluctuated over the past 5 years, first surged by 24808.63% in 2021, then tumbled by 2617.15% in 2022.
  • Over the past 5 years, UiPath's Research & Development (Quarter) stood at $61.6 million in 2021, then increased by 9.39% to $67.3 million in 2022, then grew by 25.5% to $84.5 million in 2023, then grew by 14.75% to $97.0 million in 2024, then dropped by 0.11% to $96.9 million in 2025.
  • Its Research & Development stands at $96.9 million for Q4 2025, versus $98.3 million for Q3 2025 and $94.8 million for Q2 2025.